We provide third-party COA testing documentation so researchers can independently verify the identity and purity of the compounds they are working with
Engineered for continuous, direct-to-bloodstream delivery, this patch provides effective doses of both NAD+ and BPC-157, supporting sustained energy, cellular repair, and tissue recovery in one convenient, non-invasive solution
The stable gastric pentadecapeptide BPC 157, an original cytoprotective antiulcer peptide that is used in ulcerative colitis and recently in a multiple sclerosis trial and that has an LD1 that has not been achieved [1,2,3,4,5,6,7,8,9,10,11], is known to have pleiotropic beneficial effects [1,2,3,4,5,6,7,8,9,10,11] and to interact with several molecular pathways [2, 27,28,29,30,31,32]
Cycle Length: Research protocols commonly run for 4 to 6 weeks, followed by a break of at least that long